National Action Plan for the Prevention and Control of Noncommunicable Diseases 2015-2020

NCDs are the main cause of mortality and morbidity in Suriname, as is the case in most of the countries in the world. At the UN High Level Meeting in September 2011, Suriname endorsed the UN resolution on NCDs, immediately after which the government assigned a special budget to the MOH to support prevention and control activities in the area of NCDs. This illustrates that the government takes up its own responsibility in the fight against the epidemic of NCDs. One of the first priorities has been the development of this National Action Plan for the Prevention and Control of NCDs which provides a framework for a coordinated and integrated approach during the coming years in the fight against NCDs in our country. The elements of the NCD plan focus on public awareness of the NCD burden, healthy lifestyle promotion, health systems strengthening, strengthening of the legal framework, strengthening of surveillance and operational research and the strengthening of monitoring and evaluation systems. For the coming years the priority NCDs namely cancer, diabetes, and cardiovascular disease which account for 60% of mortality nationwide will be targeted. Another priority health area which also will be included is mental health and substance abuse. The fight against NCDs cannot be successful without a strong intersectoral collaboration which is crucial for healthy lifestyle promotion and risk factor reduction. This plan calls for a collective effort through the establishment of structured intersectoral cooperation with other ministries, private sector and civil society. Periodic evaluations are an essential part of the fight of all diseases and specifically of NCDs which require more complex interventions than the communicable diseases. This NCD plan is a dynamic document which will be periodically revised in order to enable us to keep on track towards the goals set. As health sector and as a nation we have to join hands, be accountable and share responsibility to be able to really tackle the burden of NCDs. We owe it to the next generation.

Ministry of Health Malaria Program Suriname: Annual report 2017: Towards malaria elimination -- Test, treat and track

Suriname was responsible for the highest concentration of Plasmodium falciparum malaria in the Americas prior to 2006. Since 2006 the country experienced a significant decrease in malaria incidence, reaching near elimination levels by 2009. The country is currently listed by the World Health Organization (WHO) among the countries with the potential to eliminate malaria by 2020. The 2017 Annual Report of the Ministry of Health Malaria Program of Suriname outlines the ongoing, nationally adopted strategies aimed at achieving the elimination of Malaria by the target date, especially in light of diminishing funding from international aid organizations

Ongoing surveillance of Zika sequelae

This document outlines the typical symptoms of the Zika virus as well as some of the surveillance strategies being adopted by the Epidemiology Department of the Bureau of Public Health (BOG) at the Ministry of Health, Suriname at both primary and secondary levels of the health care system

Zika update, June 9, 2017 Suriname

The update reports on surveillance with regard to the Zika virus from its inception in Suriname in November 2015, to June 2017. It comprises of statistical data inclusive of a map and several charts representing suspected and confirmed cases of Zika. Brief information on Guillain-Barre Syndrome, Congenital Syndrome and Zika associated deaths due to other pre-existing illnesses are also contained in the report.

Zika cases: Epi Week 22, 2017

This table contains numerical data sourced from surveillance of cases related to Zika Virus disease and Guillain-Barré Syndrome (GBS). Entries began in the year 2015, Month 8, Epidemiological Week 32 and ended in 2017, Month 5, Epidemiological Week 22. They were made under the following headings: Zika Disease Confirmed case; Zika disease Suspected case; Cases of GBS; Cases of GBS lab­ confirmed for ZIKV; Other Neurological Syndromes; Other Neurological Syndromes lab­ confirmed for ZIKV; Suspected Cases of Congenital Syndrome Associated with ZIKV; Probable Cases of Congenital Syndrome Associated with ZIKV; and Confirmed Cases of Congenital Syndrome Associated with ZIKV. A total for each of the categories listed was displayed.